<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02538133</url>
  </required_header>
  <id_info>
    <org_study_id>49RC14_0072</org_study_id>
    <secondary_id>2015-001342-28</secondary_id>
    <nct_id>NCT02538133</nct_id>
  </id_info>
  <brief_title>Study Assessing Hybrid SPECT-CT With Labeled Leukocytes for Diagnosis of Vascular Prosthesis Infections</brief_title>
  <acronym>LEUCOPRO</acronym>
  <official_title>Tomoscintigraphie Hybride Aux Leucocytes Marqués Dans le Diagnostic Des Infections de Prothèses Vasculaires.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vascular Prothesis Infection is a rare but an extremely serious complication. Diagnosis is
      often difficult (germs are found only in 50% of cases). Conventional imagery is often
      non-specific and difficult to interpret especially in early postoperative phase. Leukocytes
      isolated from the patient's blood are labeled with a radiopharmaceutical technetium
      99mTc-HMPAO.

      The aim of this study is to assess the overall diagnostic performance of scintigraphy (hybrid
      SPEC-CT) with labeled leucocytes in diagnosis of subdiaphragmatic vascular prothesis
      infection.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients correctly classified by interpreting scintigraphy for the diagnosis of vascular prosthesis infection. The percentage of patients correctly classified is assessed comparing with the diagnostic established by the expert committee.</measure>
    <time_frame>One year after inclusion when vascular prosthesis infection is suspected and hybrid SPEC-CT with labeled leukocytes has been performed.</time_frame>
    <description>A visual analysis of scintigraphy for diagnosing vascular prosthesis infection. Scintigraphy is considered positive if at least one abnormal localization is seen at vascular prosthesis and if intensity is increasing over time on 20-24h delayed images.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Vascular Prosthesis Infection</condition>
  <arm_group>
    <arm_group_label>99mTc-Exametazime (HMPAO)-labeled leucocytes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>99mTc-Exametazime (HMPAO)-labeled leukocytes</intervention_name>
    <description>Hybrid tomoscintigraphy with labeled leucocytes for patients with suspected vascular prosthesis infection</description>
    <arm_group_label>99mTc-Exametazime (HMPAO)-labeled leucocytes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient of more than 18 years old

          -  Patient with a subdiaphragmatic vascular prosthesis

          -  Vascular prosthesis infection suspected with clinical (flow from the scare and/or
             local pain and/or erythema and/or persistent fever and/or bacteraemia) and/or
             biological (inflammatory syndrome : elevated C-reactive protein and/or erythrocyte
             sedimentation rate (ESR) and/or white blood cells increased) infection signs

          -  Patient willing to participate with a signed informed consent

          -  Patient covered by a healthcare insurance

        Exclusion Criteria:

          -  Pregnant women or of childbearing age without effective contraception

          -  Prosthesis limited to a bare stent.

          -  Patient who has been committed to an institution by legal or regulatory order

          -  Contraindications for labeled leukocytes scintigraphy realization :

          -  Restlessness, inability to keep still lie at least 1 hour

          -  Claustrophobia

          -  Poor compliance predictable or impaired general condition making it impossible to
             carry out the examination

          -  Refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HERVE RAKOTONIRINA, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Angers, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>HERVE RAKOTONIRINA, Dr</last_name>
    <phone>+33(0)241353412</phone>
    <email>HeRakotonirina@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé Rakotonirina</last_name>
    </contact>
    <investigator>
      <last_name>Hervé Rakotonirina</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie Rabier</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Picquet</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Le Mans</city>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene Loubiere</last_name>
    </contact>
    <investigator>
      <last_name>Hélène Loubière</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hikombo Hitoto</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mammar Hachemi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nabil Chakfe</last_name>
    </contact>
    <investigator>
      <last_name>Nabil Chakfe</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Christmann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Céline Heimburger</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyrille Blondet</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yves Hansmann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabien Thaveau</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathieu Roussin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>August 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2015</study_first_posted>
  <last_update_submitted>May 2, 2016</last_update_submitted>
  <last_update_submitted_qc>May 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>99mTc-Exametazime (HMPAO)-Labeled Leukocytes</keyword>
  <keyword>suspected subdiaphragmatic vascular prosthesis infection</keyword>
  <keyword>diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

